E-LIB Suche - Ergebnisse für: Conway, Jeffrey S.

1

Predicting Perceptions of Team Process Using Optimal Distin..:

Way, Jason D. ; Conway, Jeffrey S. ; Shockley, Kristen M..
Small Group Research. 53 (2021) 3 - p. 464-489 , 2021

2

Predicting disability and mortality in CV2/CRMP5‐IgG associ..:

Uysal, Sanem P. ; Li, Yadi ; Thompson, Nicolas R....
Annals of Clinical and Translational Neurology. 11 (2024) 3 - p. 710-718 , 2024

Link: https://doi.org/10.1002/..

3

The impact of cigarette smoking on cognitive processing spe..:

Alshehri, Ebtesam ; Cohen, Jeffrey A ; Ontaneda, Daniel...
Multiple Sclerosis Journal. 29 (2023) 7 - p. 846-855 , 2023

Link: https://doi.org/10.1177/..

4

Routine Cognitive Processing Speed Assessment in Clinical P..:

Macaron, Gabrielle ; Nakamura, Kunio ; Conway, Devon S...
Multiple Sclerosis and Related Disorders. 37 (2020) - p. 101547 , 2020

Link: https://doi.org/10.1016/..

5

Technology-enabled assessments to enhance multiple sclerosi..:

Macaron, Gabrielle ; Moss, Brandon P. ; Li, Hong...
Neurology Clinical Practice. 10 (2020) 3 - p. 222-231 , 2020

Link: https://doi.org/10.1212/..

6

Technology-enabled comprehensive characterization of multip..:

Baldassari, Laura E ; Nakamura, Kunio ; Moss, Brandon P...
Multiple Sclerosis and Related Disorders. 38 (2020) - p. 101525 , 2020

Link: https://doi.org/10.1016/..

7

Multiple Sclerosis: Unprecedented Progress But Significant ..:

Conway, Devon S. ; Hua, Le H. ; Cohen, Jeffrey A.
Neurotherapeutics. 14 (2017) 4 - p. 832-834 , 2017

Link: https://doi.org/10.1007/..

8

Sphingosine 1-Phosphate Receptor Modulators for the Treatme..:

Chaudhry, Burhan Z. ; Cohen, Jeffrey A. ; Conway, Devon S.
Neurotherapeutics. 14 (2017) 4 - p. 859-873 , 2017

Link: https://doi.org/10.1007/..

9

Discovery of Stromal Regulatory Networks that Suppress Ras-..:

Liu, Huayang ; Dowdle, James A. ; Khurshid, Safiya...
Developmental Cell. 41 (2017) 4 - p. 392-407.e6 , 2017

Link: https://doi.org/10.1016/..

10

Influence of hypertension, diabetes, hyperlipidemia, and ob..:

Conway, Devon S ; Thompson, Nicolas R ; Cohen, Jeffrey A
Multiple Sclerosis Journal. 23 (2016) 2 - p. 277-285 , 2016

Link: https://doi.org/10.1177/..

11

Lack of magnetic resonance imaging lesion activity as a tre..:

Conway, Devon S. ; Thompson, Nicolas R. ; Cohen, Jeffrey A.
Multiple Sclerosis and Related Disorders. 9 (2016) - p. 129-134 , 2016

Link: https://doi.org/10.1016/..

12

Natalizumab and fingolimod: Insight into their relative eff..:

Conway, Devon S ; Cohen, Jeffrey A
Multiple Sclerosis Journal. 20 (2014) 10 - p. 1280-1281 , 2014

Link: https://doi.org/10.1177/..

13

Factors associated with clinically significant increased wa..:

Miller, Deborah M ; Thompson, Nicolas R ; Cohen, Jeffrey A...
Multiple Sclerosis Journal. 21 (2014) 4 - p. 457-465 , 2014

Link: https://doi.org/10.1177/..

14

A Long-Acting Human Growth Hormone With Delayed Clearance (..:

Yuen, Kevin C. J. ; Conway, Gerard S. ; Popovic, Vera...
The Journal of Clinical Endocrinology & Metabolism. 98 (2013) 6 - p. 2595-2603 , 2013

Link: https://doi.org/10.1210/..

15

Long term benefit of multiple sclerosis treatment: an inves..:

Conway, Devon S ; Miller, Deborah M ; O'Brien, Ralph G.
Multiple Sclerosis Journal. 18 (2012) 11 - p. 1617-1624 , 2012

Link: https://doi.org/10.1177/..